PE Anti-Mouse CD69 Antibody[H1.2F3]

The PE Anti-Mouse CD69 Antibody [H1.2F3] is a highly specific and reliable tool designed for the detection and analysis of CD69 expression in mouse samples. This antibody is conjugated with phycoerythrin (PE), a fluorescent dye that emits a strong signal upon excitation, enabling easy visualization and quantification of CD69-positive cells.

CD69 is an early activation marker expressed on the surface of various immune cells, including T cells, B cells, and natural killer cells. Its upregulation is associated with immune response initiation and plays a crucial role in immune cell activation, proliferation, and cytokine production. Therefore, the PE Anti-Mouse CD69 Antibody [H1.2F3] serves as an invaluable tool for researchers studying immune cell activation, immune response modulation, and related fields.

This antibody has been extensively validated for its specificity and sensitivity, ensuring accurate and reproducible results. It exhibits minimal cross-reactivity with other antigens, guaranteeing reliable detection of CD69 expression without interference from non-specific binding. Additionally, the PE conjugation provides enhanced signal intensity, allowing for the detection of low-abundance CD69-positive cells.

The PE Anti-Mouse CD69 Antibody [H1.2F3] is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming antibody labeling procedures. It is suitable for various applications, including flow cytometry, immunofluorescence, and immunohistochemistry. The antibody is compatible with a wide range of sample types, including whole blood, lymphoid tissues, and cell cultures.

With its exceptional specificity, sensitivity, and ease of use, the PE Anti-Mouse CD69 Antibody [H1.2F3] is an indispensable tool for researchers in immunology, oncology, and other related fields. It enables accurate and efficient analysis of CD69 expression, facilitating a deeper understanding of immune cell activation mechanisms and their implications in various diseases and therapeutic interventions.